Position in DHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$120,002
+$554 QoQ
Shares Held
630
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,806
of 2,092 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HOLLENCREST CAPITAL MANAGEMENT holds $874,068 across 6 Diagnostics & Research names. DHR ranks #2 (13.7% of the industry book) .
All Filings in DHR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,002 | 630 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $119,448 | 630 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $144,219 | 630 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $124,903 | 630 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $124,450 | 630 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $129,150 | 630 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $153,109 | 667 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $185,439 | 667 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $162,402 | 650 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $162,318 | 650 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $483,037 | 2,088 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $570,381 | 2,299 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $564,480 | 2,352 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $592,798 | 2,352 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $247,902 | 934 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $234,268 | 907 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $229,942 | 907 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $266,050 | 907 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $301,701 | 917 | Shares | Sole | 2022-01-07 | |
| No filing history on record for this holder in this stock. | ||||||